Sickle cell disease

There are 43 papers on sickle cell disease in aging research: 2 trials and 23 observational studies in people, 9 in animals, 1 in cells, 8 reviews. The newest story, Nov 16, 2026: “Sickle cell mice showed early aging-like changes in blood”.

Disease

43 papers study it9 more mention it19 findings

4 new papers in 30 daysSee all 52 papers on sickle cell disease

“1503 (12.2%, 95% CI: 11.58-12.74) had screening-detected, hidden sickle cell status”
Hidden morbidity in early adulthood: Discrepancies between self-reported and screening-detected health conditions among university students in GhanaGlobal epidemiology2026doi:10.1016/j.gloepi.2026.100285
  • Human trial2
  • Humans23
  • Animals9
  • Cells1

Effects

10

Clonal hematopoiesis of indeterminate potential

no changein humans1upin humans1OR 4.2

2 studies
  1. Sickle cell disease was not clearly linked with clonal hematopoiesis of indeterminate potential in humans (at baseline compared to donor controls).

    “Baseline CH prevalence was similar in recipients and donors”

    Humansat baseline compared to donor controlswhole bloodn = 98

    Characteristics of donor and recipient clonal hematopoiesis in nonmyeloablative transplant for sickle cell disease

    Blood

  2. Sickle cell disease is linked with higher clonal hematopoiesis of indeterminate potential in humans (OR 4.2; P = 7.4 × 10-13).

    “children with SCD have a significantly higher prevalence of CH than the comparison group (odds ratio [OR], 4.2; P = 7.4 × 10-13)”

    Humanschildren aged 0 to 18 years, compared with age-, sex-, and race-matched children without SCD

    Increased prevalence of clonal hematopoiesis in children with sickle cell disease

    Blood

More on Clonal hematopoiesis of indeterminate potential

Clonal hematopoiesis burden

upin mice1

1 study
  1. Sickle cell disease increases clonal hematopoiesis burden in mice (Humanized sickle cell disease mice compared with matched normal controls).

    “a high proportion of SCD mice developed hematopoiesis with dysplastic features reminiscent of MDS morphology and higher clonal hematopoiesis burden.”

    AnimalsHumanized sickle cell disease mice compared with matched normal controls

    Sickle cell mice showed early aging-like changes in blood

    Blood

More on Clonal hematopoiesis burden

Myeloid-biased hematopoiesis

upin mice1

1 study
  1. Sickle cell disease increases myeloid-biased hematopoiesis in mice (Humanized sickle cell disease mice compared with matched normal controls).

    “Unlike controls, SCD mice showed an 'ageing-like' phenotype with premature development of myeloid-biased hematopoiesis”

    AnimalsHumanized sickle cell disease mice compared with matched normal controlsblood and bone marrow

    Sickle cell mice showed early aging-like changes in blood

    Blood

Senescent T-cell frequency

no changein humans1

1 study
  1. Sickle cell disease was not clearly linked with Senescent T-cell frequency in humans (sickle cell disease patients compared with healthy donors).

    “SCD patients (n = 21) and HDs (n = 15) had similar frequencies of CD3+CD4+ Tsen and CD3+CD8+ Tsen cells.”

    Humanssickle cell disease patients compared with healthy donorsperipheral blood

    Analysis of the lymphocyte memory and senescence profile of patients with sickle cell disease

    Hematology Transfusion and Cell Therapy

More on Senescent T-cell frequency

Hematopoietic colony-forming ability

downin human cells1

1 study
  1. Sickle cell disease impairs hematopoietic colony-forming ability in human cells (ex vivo culture of human bone marrow HSPCs).

    “human SCD bone marrow HSPCs exhibited poor ex vivo hematopoietic colony-forming ability”

    Cellsex vivo culture of human bone marrow HSPCsbone marrow

    Drugs improve blood-forming cell function in sickle cell mice

    Science translational medicine

Hematopoietic stem cell function

downin mice1

1 study
  1. Sickle cell disease impairs hematopoietic stem cell function in SCD mice (marked loss (no number stated)).

    “SCD mice displayed a marked loss of immunophenotypic bone marrow HSPCs by flow cytometry and functional blood repopulating HSPCs in transplantation studies”

    Animalsin SCD micebone marrow

    Drugs improve blood-forming cell function in sickle cell mice

    Science translational medicine

Proteomic age

upin humans1

1 study
  1. Sickle cell disease is linked with higher proteomic age in humans (patients with SCD) (+6.0 ± 5.4 years).

    “confirmed that SCD patients age prematurely (+6.0 ± 5.4 years older than their chronological age)”

    Humanspatients with SCDn = 376

    Plasma proteome signatures are predictive of mortality in sickle cell disease

    Blood advances

More on Proteomic age

Biological age

upin humans1

1 study
  1. Sickle cell disease is linked with higher biological age in humans (vs. similarly aged individuals without SCD) (43 years).

    “a gap of 43 years in biological age - consistent with accelerated aging in the SCD population.”

    Humansvs. similarly aged individuals without SCD

    Adolescents and young adults with sickle cell disease exhibit accelerated aging with elevated T-cell p16INK4a expression

    Aging

More on Biological age

CDKN2A

upin humans1

1 study
  1. Sickle cell disease is linked with higher CDKN2A in humans (vs. similarly aged individuals without SCD) (10.1 vs. 8.7 log2 p16 units, p < 0.001).

    “Expression of p16 was dramatically higher in individuals with SCD vs. without SCD (10.1 vs. 8.7 log2 p16 units, respectively, p < 0.001)”

    Humansvs. similarly aged individuals without SCD

    Adolescents and young adults with sickle cell disease exhibit accelerated aging with elevated T-cell p16INK4a expression

    Aging

More on CDKN2A

DunedinPACE

upin humans1

1 study
  1. Sickle cell disease is linked with higher DunedinPACE in humans (Black Americans with SCD vs without SCD) (mean difference of 0.057 points, ≈0.7 months more per year, p = 4.49 × 10-8).

    “SCD patients displayed a significantly accelerated pace of aging (DunedinPACE mean difference of 0.057 points) compared with the veterans without SCD”

    HumansBlack Americans with SCD vs without SCD

    Black Americans With Sickle Cell Disease (SCD) Demonstrate Accelerated Epigenetic Pace of Aging Compared to Black Americans Without SCD

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on DunedinPACE

Associations

8

Incident ischemic stroke

upin humans1HR 5.12

1 study
  1. Sickle cell disease is associated with incident ischemic stroke in humans (Homozygous variant HbSS versus homozygous reference HbAA) (HR 5.12, 95% CI 2.96-8.85; p < 0.001).

    “In contrast, HbSS was associated with a markedly elevated hazard of ischemic stroke”

    HumansHomozygous variant HbSS versus homozygous reference HbAAn = 144

    Sickle cell trait showed no clear link to stroke in adults

    Neurology. Genetics

More on Incident ischemic stroke

Age at menopause

downin humans1

1 study
  1. Sickle cell disease is associated with age at menopause in humans (sickle cell disease).

    “We highlight emerging evidence suggesting earlier menopause in women with SCD”

    Reviewsickle cell diseasefemales

    From menarche to menopause: a lifespan perspective on women's health in sickle cell disease

    Frontiers in epidemiology

University students

upin humans1

1 study
  1. University students are associated with sickle cell disease in humans (12.2% (95% CI: 11.58-12.74)).

    “1503 (12.2%, 95% CI: 11.58-12.74) had screening-detected, hidden sickle cell status”

    Humansn = 12,360

    Hidden morbidity in early adulthood: Discrepancies between self-reported and screening-detected health conditions among university students in Ghana

    Global epidemiology

More on University students

DDR-mutant clonal hematopoiesis

upin humans1

1 study
  1. Sickle cell disease is associated with DDR-mutant clonal hematopoiesis in humans (involving TP53, PPM1D, ATM, and CHEK2 compared with donors without SCD) (3.8-fold higher odds).

    “recipients with SCD had 3.8-fold higher odds of DNA damage response (DDR)-mutant CH involving TP53, PPM1D, ATM, and CHEK2 compared with donors without SCD”

    Humansinvolving TP53, PPM1D, ATM, and CHEK2 compared with donors without SCDwhole bloodn = 98

    Characteristics of donor and recipient clonal hematopoiesis in nonmyeloablative transplant for sickle cell disease

    Blood

More on DDR-mutant clonal hematopoiesis

Albuminuria

upin humans1+47%

1 study
  1. Sickle cell disease is associated with albuminuria in patients with SCD (47.2%).

    “The study found the prevalence of albuminuria to be 47.2% among patients with SCD in ABUTH Zaria.”

    Humansin patients with SCDn = 210

    Kidney function among adult sickle cell disease patients at Ahmadu Bello University Teaching Hospital, Zaria, Nigeria

    BMC nephrology

More on Albuminuria

Biological age

upin humans1

1 study
  1. Sickle cell disease is associated with biological age in humans (adults with sickle cell disease).

    “Recently developed clocks more consistently demonstrated acceleration (GrimAge, DunedinPACE).”

    Humansadults with sickle cell diseasen = 89

    Characterizing epigenetic aging in an adult sickle cell disease cohort

    Blood advances

Slow gait speed

upin humans1

1 study
  1. Sickle cell disease is associated with slow gait speed in humans (sickle cell disease) (63% (25/40)).

    “63% (25/40) had a slow usual gait speed (< 1.2 m/s)”

    Humanssickle cell diseasen = 40

    The Sickle Cell Disease Functional Assessment (SCD-FA) tool: a feasibility pilot study

    Pilot and feasibility studies

Mitochondria-retaining red blood cells

upin humans1

1 study
  1. Sickle cell disease is associated with mitochondria-retaining red blood cells in humans (compared with healthy individuals).

    “we observed an increased percentage of RBCs retaining mitochondria in SCD patient blood samples compared with healthy individuals”

    Humanscompared with healthy individualsred blood cells

    Pharmacological inhibition of LSD1 and mTOR reduces mitochondrial retention and associated ROS levels in the red blood cells of sickle cell disease

    Experimental hematology

More on Mitochondria-retaining red blood cells

Trial sponsors

Funding

18 grants since 2018

National Heart, Lung, and Blood Institute$16.9MNational Institute of Neurological Disorders and Stroke$3MNational Institute of Nursing Research$824K

Latest

Dec 2025: 1Jan 2026: 2Feb 2026: 2Mar 2026: 5Apr 2026: 2May 2026: 2Jun 2026: 2Jul 2026: 2Aug 2026: 2Sep 2026: 1Oct 2026: 7Nov 2026: 230 papers in 12 months
Blood

Sickle cell mice showed early aging-like changes in blood

Mice followed up to one year of age showed abnormal blood formation, while repeated stem cell transplants increased mutations in blood-forming cells.Mice followed up to one year of age showed abnormal blood formation, while repeated stem cell transplants increased mutations in blood-forming cells.

Mouse studyMechanisms
Neurology Genetics

Sickle cell trait showed no clear link to stroke in adults

After adjustment, adults with the trait had a relative hazard of 1.06 for strokes from blocked blood flow compared with adults without the variant.After adjustment, adults with the trait had a relative hazard of 1.06 for strokes from blocked blood flow compared with adults without the variant.

Cohort · 275,530 peopleSickle cell disease

See all 52 papers on sickle cell disease